Health Science Policy Council Chair 2025 - 2027
Deborah Marshall, PhD, BSc
Professor, Scientific Director Value and Impact, Alberta Children's Hospital Research Institute, University of Calgary
Calgary, AB, Canada
Past Chair 2025-2027
Maarten IJzerman, MSc, PhD
Dean and Professor Cancer Health Services Research, Erasmus School of Health Policy & Management
Rotterdam, Netherlands
Chair-Elect 2025 - 2027
Peter Neumann, ScD
Director, Center for the Evaluation of Value and Risk, Tufts Medical Center
Boston, MA, United States
Health Science Policy Council Members
Science/Research Committee
Co-Chairs
Reed Johnson, PhD
Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States
Vivian Lee, PharmD, BSc
Associate Professor, The Chinese University of Hong Kong
Shatin, 91, China
Members
Alan Balch
CEO, Patient Advocate Foundation and National Patient Advocate Foundation
Hampton, VA, United States
Eric Barrette
Senior Director, Health Economics, Medtronic
Minneapolis, MN, United States
Andrew Briggs, DPhil
Professor of Health Economics, London School of Hygiene & Tropical Medicine
London, LON, United Kingdom
J. Jaime Caro, MD
Chief Scientist, Thermo Fisher Scientific
Lincoln, MA, United States
Amanda Cole, PhD, BSc
Director, Office of Health Economics
London, LON, United Kingdom
Paolo Angelo Cortesi, PhD
Assistant Professor, Research Centre on Public Health (CESP), University of Milan-Bicocca
Monza, MB, Italy
William Crown, PhD, BA, MA
Distinguished Research scientist, Brandeis University
Waltham, MA, United States
Jessica Daw, MBA, PharmD
Vice President, Pharmacy, Sentara Health Plans
Virginia Beach, VA, United States
Nancy Devlin, PhD, BA
Professor of Health Economics, University of Melbourne
Melbourne, VIC, Australia
Eduardo Gonzalez-Pier, PhD
Distinguished Fellow, Center for Global Development
Cuidad de Mexico, Mexico
Maarten IJzerman, MSc, PhD
Dean and Professor Cancer Health Services Research, Erasmus School of Health Policy & Management
Rotterdam, Netherlands
Zoltan Kalo, PhD
Professor of Health Economics, Center for Health Technology Assessment, Semmelweis University & Syreon Research Institute
Budapest, PE, Hungary
Stacey Kowal, MSc, BS
Senior Director, Genentech
Alameda, CA, United States
Bradley Martin, PharmD, RPh, PhD
Professor, University of Arkansas for Medical Sciences (UAMS)
Little Rock, AR, United States
Soumana Nasser, PharmD
Associate Professor, Pharmacy Practice Department, Lebanese American University
Byblos, BA, Lebanon
Hwee-Lin Wee, PhD
Associate Professor, National University of Singapore
Singapore, Singapore
Task Force Review Committee
Co-Chairs
Joseph Cappelleri, MS, PhD, MPH
Executive Director of Biostatistics, Pfizer Inc
Newington, CT, United States
Mark Sculpher, MSc, PhD, BA
Professor and Director of Center for Health Economics, University of York
York, NYK, United Kingdom
Members
Rachael Fleurence, PhD
Value Analytics Labs
Boston, MA, United States
Lou Garrison, PhD
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute
Seattle, WA, United States
Lorenzo G Mantovani, ScD
Center for Public Health Research, University of Milan Bicocca
Monza, MB, Italy
Deborah Marshall, PhD, BSc
Professor, Scientific Director Value and Impact, Alberta Children's Hospital Research Institute, University of Calgary
Calgary, AB, Canada
Eberechukwu Onukwugha, MS, PhD, BA
Professor, University of Maryland, School of Pharmacy
Baltimore, MD, United States
Brian O'Rourke, PharmD
President, Brian O'Rourke Health Care Consulting Inc.
Ottawa, ON, Canada
Julia F. Slejko, PhD
Associate Professor, University of Maryland School of Pharmacy
Baltimore, MD, United States
Lotte Steuten, MSc, PhD
Deputy Chief Executive, Office of Health Economics
London, LON, United Kingdom
Praveen Thokala, PhD, MASc
SCHARR, University of Sheffield
Sheffield, United Kingdom
Adrian Towse, Mphil, MA
Senior Visiting Fellow, Office of Health Economics
London, LON, United Kingdom
Zsombor Zrubka, MBA, MD
Associate Professor, Óbuda University
Budapest, PE, Hungary